Jefferies has issued a 'Buy' recommendation for Sun Pharma with a target price of ₹2,150 per share, citing potential peak sales of $100 million from its latest cancer treatment assets. Meanwhile, CLSA rates NHPC as 'Outperform', reflecting positive sentiment in the market.Godrej Consumer Products also received a 'Buy' call from Jefferies, targeting ₹1,550 per share, despite anticipated volume declines in soaps and home insecticides. Motilal Oswal has a 'Buy' rating on Reliance Industries, targeting ₹1,580 per share, highlighting strong free cash flow generation and growth prospects in various segments.